-
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change
Tuesday, July 19, 2022 - 3:51pm | 637Read More...Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications. This is the first step in the process of receiving a patent, which needs to be granted by an overseeing body. Mydecine's Patent On The MYCO-006 Family Of Compounds...
-
The Legacy Of Dr. Aaron Beck, Father Of Cognitive Therapy, Lives On In Psychedelic Medicine
Thursday, November 4, 2021 - 7:41am | 913Read More...Dr. Aaron T. Beck, the father of cognitive therapy, died on Monday at his home in Philadelphia at age 100. Beck’s contributions to the fields of psychology and psychiatry have had a tremendous influence on the way mental health treatment is administered today, marking one of the most...
-
Mydecine Innovations Inks Deal With Johns Hopkins University To Undertake Psychedelics Research Into Smoking Cessation
Wednesday, August 18, 2021 - 4:57pm | 172Read More...Mydecine Innovations Group (NEO: MYCO) (OTCPINK: MYCOF) has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, to study the application of psychedelics molecules and therapies in smoking cessation. The research will be led by Dr. Matthew W. Johnson,...
